Previous Article | Next Article 
Journal of Clinical Microbiology, January 1998, p. 90-93, Vol. 36, No. 1
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Pre-AIDS Era Isolates of Pneumocystis
carinii f. sp. hominis: High Genotypic Similarity with
Contemporary Isolates
Anthony G.
Tsolaki,1
Pieter
Beckers,2 and
Ann E.
Wakefield1,*
Molecular Infectious Diseases Group,
Department of Paediatrics, Institute of Molecular Medicine, John
Radcliffe Hospital, Oxford, OX3 9DS, United
Kingdom,1 and
Department of Medical
Microbiology, University Hospital Nijmegen, Nijmegen, The
Netherlands2
Received 30 July 1997/Returned for modification 10 September
1997/Accepted 8 October 1997
 |
ABSTRACT |
Isolates of Pneumocystis carinii f. sp.
hominis were examined from six individuals who died of
P. carinii pneumonia between 1968 and 1981 and who had
underlying immunodeficiencies which were not due to human
immunodeficiency virus infection. DNA sequence variation was analyzed
in the genes encoding the mitochondrial large subunit rRNA (mt LSU
rRNA), the internal transcribed spacer (ITS) regions of the nuclear
rRNA, the arom locus, and the mitochondrial small subunit
rRNA. No major variations were observed when these isolates were
compared to isolates from HIV-infected individuals. A small number of
minor differences were detected. A new position at which variation
occurred in the mt LSU rRNA was observed in one sample. Three new ITS
sequence types were identified. A total of nine different ITS sequence
types were found in the six samples. Mixed infection with different ITS
sequence types of P. carinii f. sp. hominis was
observed in four of the six samples. The ITS locus was the most
informative of the four loci for distinguishing among the isolates of
P. carinii f. sp. hominis. The data suggest that isolates of P. carinii f. sp. hominis from
before the AIDS pandemic are genetically very similar to those
currently found in HIV-infected individuals.
 |
INTRODUCTION |
The opportunistic fungus
Pneumocystis carinii causes potentially fatal pneumonia in
immunocompromised individuals. In the past, the majority of incidence
of P. carinii pneumonia were in individuals with congenital
immunodeficiencies and in patients receiving immunosuppressive therapy
for organ transplantation or undergoing chemotherapy for the treatment
of malignant disease. In recent years, however, there has been a large
increase in the incidence of P. carinii pneumonia, primarily
in individuals immunocompromised by infection with human
immunodeficiency virus (HIV) (5, 21).
Recently developed molecular techniques have enabled the typing of
P. carinii f. sp. hominis (human-derived P. carinii) (17). Since the organism cannot be propagated
by in vitro culture, pure isolates of parasite cannot be
obtained and standard methods of typing cannot be utilized. However,
different types of P. carinii f. sp. hominis have
been identified by the comparison of DNA sequences at a number of
genetic loci. A portion of the gene encoding the mitochondrial large
subunit rRNA (mt LSU rRNA) has been used to study genetic variation
among isolates of P. carinii f. sp. hominis from
HIV-infected patients in the United States (11), France, Italy (9, 10), the United Kingdom, Africa, and South America (19) and from HIV-infected patients with recurrent episodes of P. carinii pneumonia (7, 8).
Genetic diversity has also been reported among isolates of
P. carinii f. sp. hominis at a portion
of the arom gene, in the region encoding the
5-enolpyruvylshikimate-3-phosphate (EPSP) synthase activity,
involved in aromatic amino acid biosynthesis (1). The
presence of more than one type of P. carinii f. sp. hominis in a single infected lung has been demonstrated by
the typing of isolates at this single-copy-number gene (1).
The sequences of the internal transcribed spacer (ITS) regions of the
nuclear rRNA operon have also been shown to vary among isolates of
P. carinii f. sp. hominis (9, 12, 13).
The ITS regions have been used to investigate variation among isolates of P. carinii f. sp. hominis from HIV-infected
patients with recurrent episodes of P. carinii pneumonia
(15).
In this study we have examined archival isolates of P. carinii f. sp. hominis from six individuals who had a
variety of underlying immunodeficiencies but were not infected with
HIV. The samples dated from the period 1968 to 1981, before the onset
of the AIDS pandemic. The aim of the study was to compare the nature
and extent of diversity in these samples, from a period when P. carinii pneumonia was a rare disease, with organisms isolated from
HIV-infected individuals. Genetic diversity was examined in the genes
encoding the mt LSU rRNA locus and the ITS regions. In addition,
variations in the genes encoding the arom locus and the
mitochondrial small subunit rRNA (mt SSU rRNA) were also examined in
three of the samples.
 |
MATERIALS AND METHODS |
Samples.
Samples of P. carinii f. sp.
hominis were obtained from patients, diagnosed at the
University Hospital Nijmegen, Nijmegen, The Netherlands, who died of
P. carinii pneumonia, confirmed by histological staining,
between 1968 and 1981. Samples of lung were taken post mortem and
stored at
70°C until analysis. Clinical details for each sample are
listed in Table 1.
DNA extraction.
A small portion of lung tissue from each
sample was finely minced, homogenized with a pellet mixer in a
microcentrifuge tube, and treated with proteinase K (Boehringer
Mannheim) at a final concentration of 1 mg/ml in the presence of 0.5%
sodium dodecyl sulfate and 10 mM EDTA (pH 8.0) at 50°C overnight. Two
phenol-chloroform extractions were performed, and the DNA was purified
and concentrated with a DNA binding resin (Wizard DNA Clean-up System;
Promega, Southampton, United Kingdom) (16). Negative buffer
controls were prepared concurrently to monitor for cross-contamination.
DNA amplification.
DNA amplification was carried out on the
samples in a reaction mixture containing a final concentration of 10 mM
Tris-HCl (pH 8.8), 10 mM KCl, 0.002% Tween 20 (vol/vol), 3 mM
MgCl2, 400 mM (each) deoxynucleoside triphosphate
(Boehringer Mannheim), 1 mM (each) oligonucleotide primer, and 0.025 U
of Ultma Taq polymerase (Perkin-Elmer Cetus) per µl.
Nested PCR was used when the amount of P. carinii f. sp.
hominis DNA in the samples was low and was insufficient to
produce a visible band of amplification product on an ethidium
bromide-stained gel after a single round of amplification (Table
2). Negative controls with no added DNA
were included after each sample. An EcoRI restriction
endonuclease site was included at the 5' terminus of the
oligonucleotide primers to facilitate cloning of amplification
products. DNA amplification was performed on the samples at the mt LSU
rRNA, with a first round with the oligonucleotide primers pAZ102-H/RI
and pAZ102-E/RI (18, 20) and a second round with primers
pAZ102-X/RI and pAZ102-Y/RI (18) (Table
3). The conditions for the first- and
second-round amplifications, respectively, were denaturation at 94°C
for 1.5 min, annealing at 55°C for 1.5 min, and extension at 72°C
for 2 min for 10 cycles followed by 30 cycles at 94°C for 1.5 min, 63°C for 1.5 min, and 72°C for 2 min.
DNA amplification at the ITS regions was performed with the primers
ITSF3/RI and ITS2R3/RI. The conditions consisted of 10
cycles at 94°C
for 1.5 min, 56°C for 1.5 min, and 72°C for 2 min
and 30 cycles at
94°C for 1.5 min, 64°C for 1.5 min, and 72°C
for 2 min for a
total of 40 cycles. When a nested PCR was required,
a first-round
amplification was carried out with primer pair NITSF
and NITSR, with 40 cycles consisting of 94°C for 1.5 min, 55°C
for 1.5 min, and 72°C
for 2 min. This was followed by a second
round of amplification with
the primers ITSF3/RI and ITS2R3/RI
under the conditions described above
(
15).
DNA amplification at the EPSP synthase domain of the
arom
gene was performed by nested PCR with the first-round primers AroFunivB
and AroFunivC for 40 cycles, each consisting of 94°C for 1.5 min,
50°C for 1.5 min, and 72°C for 2 min. The primer pair HsPcaro1/RI
and HsPcaro2/RI was used for the second-round amplification, with
10 cycles at 94°C for 1.5 min, 52°C for 1.5 min, and 72°C for
2 min
followed by a second stage of 30 cycles at 94°C for 1.5
min, 63°C
for 1.5 min, and 72°C for 2 min (
1).
DNA amplification at the mt SSU rRNA was performed with the first-round
primers pAZ112-1OF/RI and pAZ112-1OR/RI, for 40 cycles,
each consisting
of 94°C for 1.5 min, 55°C for 1.5 min, and 72°C
for 2 min
(
4). The second round of amplification was carried
out with
the primer pair pAZ112-13/RI and pAZ112-14/RI, with 10
cycles at 94°C
for 1.5 min, 52°C for 1.5 min, and 72°C for 2 min,
followed by 30 cycles at 94°C for 1.5 min, 63°C for 1.5 min, and
72°C for 2 min.
Cloning and sequencing of amplification products.
The PCR
products were digested with restriction endonuclease EcoRI,
purified from 1.5% agarose gels with Geneclean II (Bio101, Stratech
Scientific, Bedfordshire, United Kingdom), and cloned into the plasmid
vector pUC18 at the EcoRI site. Recombinant plasmids were
sequenced with the M13 universal primers by the dideoxy-chain termination method. Multiple clones of each sample were sequenced. Sequence analysis was performed using the University of Wisconsin Genetics Computer Group Sequence Analysis Software Package (Version 8, April 1994, Madison, Wisconsin).
 |
RESULTS |
DNA amplification with P. carinii-specific
oligonucleotide primers was carried out on DNA extracted from
post-mortem lung samples from six individuals who died between 1968 and
1981 of P. carinii pneumonia. The amplification products
were cloned, and the sequences of the recombinants were determined.
Variation at the P. carinii f. sp. hominis
mt LSU rRNA.
A 346-bp fragment of the gene encoding the P. carinii f. sp. hominis mt LSU rRNA was amplified with a
single round of amplification from samples LT68 and SP81 and a 207-bp
fragment from the other samples by using a nested PCR. The samples were
examined for variation at base 85 and base 248, where polymorphisms
have previously been described (7-11, 14, 19). At position
85, either thymine (T) or cytosine (C) was observed (Table
4). Position 248 was spanned in only two
of the samples, which were amplified by a single round of PCR, and C
was observed in both samples. A new position at which variation
occurred was observed in one sample, SP81, at base 81, where T was
observed rather than C, as reported in the previously published
sequences. To verify this new polymorphic site, 14 clones from each of
three separate amplification reactions were analyzed. Thymine was
observed at position 81 in all the clones.
In three samples, US3846, US3885, and US4001, two different mt LSU rRNA
sequence types were observed, suggesting coinfection
with more than one
type of
P. carinii f. sp.
hominis.
Variation at the P. carinii f. sp. hominis
Internal Transcribed Spacer regions.
A 540-bp fragment spanning
the ITS regions of the nuclear rRNA operon of P. carinii f.
sp. hominis was amplified from six samples. We have
previously described 5 different ITS1 types, based on polymorphisms at
four different positions, and 7 different ITS2 types, based on
polymorphisms at six different positions, resulting in 10 different
P. carinii f. sp. hominis ITS sequence types
(Tables 5 and 6) (15).
Applying this method of typing to the samples in this study, one new
ITS1 sequence type, A3, was identified in sample US3885, in
which thymine was observed at base position 2 (Table 5). In addition,
two new ITS2 types were also observed, type a4 in sample
US3846 and type c2 in sample US3885 (Table
6). Three new ITS sequence types,
A2c2, A3c1 and B2a4, were identified in this study. No
consistent, reproducible sequence polymorphisms were observed at
positions other than those previously described. A total of nine
different ITS sequences were observed in the six samples. A single ITS
type was observed in two of the samples, US4015 and SP81, two different
ITS types were observed in each of two samples, LT68 and US4001, and
three different types were observed in each of samples US3846 and
US3885 (Table 4).
Variation at the P. carinii f. sp. hominis
arom locus.
Three of the samples, LT68, US3846 and US3885,
were also examined for variation at a 237-bp fragment of the EPSP
synthase domain of the arom locus. We have previously
described two single-base polymorphisms in this region, at base 121 and
base 208 (1). One sequence type,
C121/A208, was observed in each of the three samples investigated at this locus.
Variation at the P. carinii f. sp. hominis
mt SSU rRNA.
In a previous study, we described variation in a
portion of the mt SSU rRNA among isolates of P. carinii from
five different host species (4). In this paper, we report
two single-base polymorphisms in a 300-bp portion of the P. carinii f. sp. hominis gene, at base 160 and base 196 (numbering according to Hunter and Wakefield [4]).
Three of the samples, LT68, US3846 and US3885, were analyzed at this
locus, and two different sequence types were observed,
C160/T196, and
A160/G196, either singly or as a coinfection
(sample US3846) (Table 4).
 |
DISCUSSION |
In this study we describe the genotypic analysis of isolates of
P. carinii f. sp. hominis from six patients
during the period of 1968 to 1981, none of whom were immunocompromised
due to infection with HIV. The six samples were analyzed at two genetic
loci, and in addition, three of the samples were analyzed at a total of four different loci. The DNA sequence types determined from the samples
in this study were compared with previously published sequences. No
major differences in sequence types were observed. Where differences
were detected, they were primarily at nucleotide positions at which
variation had previously been recorded. The samples of P. carinii f. sp. hominis in this investigation differed from samples used in other typing studies in that the samples predated
the AIDS pandemic and the cause of the underlying immunodeficiency of
the patients was not HIV infection.
Although high levels of divergence from the published sequences were
not observed, some differences were detected. At the mt LSU rRNA, a new
position at which variation occurred, position 81, was found. At
position 85, both C and T were observed but not A or G. In previous
studies, C, T, and A have been recorded at this position (7-11,
19). At position 248, C was found, in keeping with previous
studies where C or T has been observed.
Variation at the P. carinii f. sp. hominis ITS
regions has been detected by DNA sequence analysis and by hybridization
with type-specific oligonucleotide probes, and four different types have been identified (12, 13). Type-specific PCR and the
technique of single-strand conformation polymorphism have also been
used in the analysis of this locus (3, 6). We have described a method of typing at this locus by DNA sequence analysis with which 10 different types of P. carinii f. sp. hominis were
identified (15). In this study, we have detected variation
only at nucleotide positions which we had previously shown to be
polymorphic. At the ITS1 region, we have identified one additional
sequence type, A3, which we had not detected in our
previous study of samples from HIV-infected patients. This ITS1
sequence type has been reported in samples from two HIV-infected
patients from Italy (9). Two new ITS2 sequence types,
a4 and c2, were also identified in this study,
which have not been reported elsewhere. Three new ITS sequence types,
A2c2, A3c1 and
B2a4 were found in this study, bringing the
total identified by this methodology to 13, of which 9 were found in
this investigation. Of the nine types identified in this study, the
type B2a1 was the most common, being present in
three of the six samples. In our previous study on samples from
HIV-infected patients, the type B2a1 was also
found as a single infection or as a coinfection in 54% of the samples
(15).
Of the four genetic loci examined in this study, the ITS locus was the
most informative. This is consistent with the results of an
investigation where diversity at the ITS regions was compared with that
of the mt LSU rRNA, the 5S rRNA, and a portion of the gene encoding
thymidylate synthase (9). In the present study, nine
different sequence types were detected in the samples at the ITS locus,
whereas only three different types were detected at the mt LSU rRNA
locus, two types were detected at the mt SSU rRNA, and one type was
detected at the arom locus. Two of the samples, US4015 and
SP81 appeared to be infected by a single type of P. carinii
f. sp. hominis. In the four other samples, two or three
different ITS sequence types were found. Since only one copy of the
nuclear rRNA operon is thought to be present in the P. carinii genome (2), our data suggest coinfection with
different types of P. carinii f. sp. hominis in
these four samples. Mixed infection, as indicated by the identification
of more than one sequence type at the ITS locus, was also reflected in
most samples (three of four samples) by two different types at the mt
LSU rRNA and also at the mt SSU rRNA (one of two samples). We have
previously reported a high incidence (33%) of mixed infections in
samples from AIDS patients (15), and mixed infections have
also been found in analyses of the mt LSU rRNA and the ITS loci
(7, 8, 9, 12, 13).
One new mt LSU rRNA sequence type and three new ITS sequence types have
been identified in this study. It remains to be established whether
these different sequence types are characteristic of samples of
P. carinii f. sp. hominis from this era, or
geographical location (The Netherlands) or underlying immunodeficiency
(non-AIDS). Analysis of a greater number of samples from a variety of
different regions of the world and with a range of underlying
immunodeficiencies will help to establish the significance of these
differences. The data from this study suggest that there has not been
any substantial change in the type of P. carinii f. sp.
hominis since the large increase in the incidence of
P. carinii pneumonia due to the AIDS pandemic.
 |
ACKNOWLEDGMENTS |
This research was supported by the Royal Society (AEW) and the
Medical Research Council (AGT). The study formed a part of the European
Concerted Action Biomed 1 research project (Pneumocystis and
pneumocystosis: impact of the biodiversity of Pneumocystis carinii on epidemiology, pathology, diagnosis, monitoring and prevention of pneumocystosis
new therapeutic approaches.
[PL941118]).
We thank the Oxford Pneumocystis Research Group for helpful discussion.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Molecular
Infectious Diseases Group, Department of Paediatrics, Institute of
Molecular Medicine, John Radcliffe Hospital, Oxford, OX3 9DS, United
Kingdom. Phone: 44-1865-222344. Fax: 44-1865-222626. E-mail:
wakefiel{at}worf.molbiol.ox.ac.uk.
 |
REFERENCES |
| 1.
|
Banerji, S.,
E. B. Lugli,
R. F. Miller, and A. E. Wakefield.
1995.
Analysis of genetic diversity at the arom locus in isolates of Pneumocystis carinii.
J. Eukaryot. Microbiol.
42:675-679[Medline].
|
| 2.
|
Giuntoli, D.,
S. L. Stringer, and J. R. Stringer.
1994.
Extraordinarily low number of ribosomal RNA genes in P. carinii.
J. Eukaryot. Microbiol.
41:88S[Medline].
|
| 3.
|
Hauser, P. M.,
D. S. Blanc,
J. Bille,
A. Telenti, and P. Francioli.
1996.
Development of molecular typing method for Pneumocystis carinii sp. f. hominis.
J. Eukaryot. Microbiol.
43:34S[Medline].
|
| 4.
|
Hunter, J. A. C., and A. E. Wakefield.
1996.
Genetic divergence at the mitochondrial small subunit ribosomal RNA gene among isolates of Pneumocystis carinii from five mammalian host species.
J. Eukaryot. Microbiol.
43:24S-25S[Medline].
|
| 5.
|
Hughes, W. T.
1987.
Pneumocystis carinii pneumonitis, vol. 1.
CRC Press, Boca Raton, Fla.
|
| 6.
|
Jiang, B.,
J.-J. Lu,
B. Li,
X. Tang,
M. S. Bartlett,
J. W. Smith, and C.-H. Lee.
1996.
Development of type-specific PCR for typing Pneumocystis carinii f. sp. hominis based on nucleotide sequence variation of internal transcribed spacer regions of rRNA genes.
J. Clin. Microbiol.
34:3245-3248[Abstract].
|
| 7.
|
Keely, S. P.,
R. P. Baughman,
A. G. Smulian,
M. N. Dohn, and J. R. Stringer.
1996.
Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients.
AIDS
10:881-888[Medline].
|
| 8.
|
Keely, S. P.,
J. R. Stringer,
R. P. Baughman,
M. J. Linke,
P. D. Walzer, and A. G. Smulian.
1995.
Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis.
J. Infect. Dis.
172:595-598[Medline].
|
| 9.
|
Latouche, S.,
E. Ortona,
E. Mazars,
P. Margutti,
E. Tamburrini,
A. Siracusano,
K. Guyot,
M. Nigou, and P. Roux.
1997.
Biodiversity of Pneumocystis carinii hominis: typing with different DNA regions.
J. Clin. Microbiol.
35:383-387[Abstract].
|
| 10.
|
Latouche, S.,
P. Roux,
J. L. Poirot,
I. Lavrard,
B. Hermelin, and V. Bertrand.
1994.
Preliminary results of Pneumocystis carinii strain differentiation by using molecular biology.
J. Clin. Microbiol.
32:3052-3053[Abstract/Free Full Text].
|
| 11.
|
Lee, C.-H.,
J.-J. Lu,
M. S. Bartlett,
M. M. Durkin,
T. H. Liu,
J. Wang,
B. Jiang, and J. W. Smith.
1993.
Nucleotide sequence variation in Pneumocystis carinii strains that infect humans.
J. Clin. Microbiol.
31:754-757[Abstract/Free Full Text].
|
| 12.
|
Lu, J.-J.,
M. S. Bartlett,
M. M. Shaw,
S. F. Queener,
J. W. Smith,
M. Ortiz-Rivera,
M. J. Leibowitz, and C.-H. Lee.
1994.
Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA gene.
J. Clin. Microbiol.
32:2904-2912[Abstract/Free Full Text].
|
| 13.
|
Lu, J.-J.,
M. S. Bartlett,
J. W. Smith, and C.-H. Lee.
1995.
Typing of Pneumocystis carinii strains with type-specific oligonucleotide probes derived from nucleotide sequences of internal transcribed spacers of rRNA genes.
J. Clin. Microbiol.
33:2973-2977[Abstract].
|
| 14.
|
Sinclair, K.,
A. E. Wakefield,
S. Banerji, and J. M. Hopkin.
1991.
Pneumocystis carinii organisms derived from rat and human hosts are genetically distinct.
Mol. Biochem. Parasitol.
45:183-184[Medline].
|
| 15.
|
Tsolaki, A. G.,
R. F. Miller,
A. P. Underwood,
S. Banerji, and A. E. Wakefield.
1996.
Genetic diversity at the internal transcribed spacer regions of the rRNA operon among isolates of Pneumocystis carinii from AIDS patients with recurrent pneumonia.
J. Infect. Dis.
174:141-156[Medline].
|
| 16.
|
Vargas, S. L.,
W. T. Hughes,
A. E. Wakefield, and H. S. Oz.
1995.
Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia.
J. Infect. Dis.
172:506-510[Medline].
|
| 17.
|
Wakefield, A. E.
1995.
Re-examination of epidemiological concepts.
Baillière's Clin. Infect. Dis.
2(3):431-448.
|
| 18.
|
Wakefield, A. E.
1996.
DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora.
J. Clin. Microbiol.
34:1754-1759[Abstract].
|
| 19.
|
Wakefield, A. E.,
C. C. Fritscher,
A. S. Malin,
L. Gwanzura,
W. T. Hughes, and R. F. Miller.
1994.
Genetic diversity in human-derived Pneumocystis carinii isolates from four geographical locations shown by analysis of mitochondrial rRNA gene sequences.
J. Clin. Microbiol.
32:2959-2961[Abstract/Free Full Text].
|
| 20.
|
Wakefield, A. E.,
F. J. Pixley,
S. Banerji,
K. Sinclair,
R. F. Miller,
E. R. Moxon, and J. M. Hopkin.
1990.
Detection of Pneumocystis carinii with DNA amplification.
Lancet
336:451-453[Medline].
|
| 21.
|
Walzer, P. D. (ed.).
1994.
Pneumocystis carinii pneumonia, 2nd ed.
Marcel Dekker, New York, N.Y.
|
Journal of Clinical Microbiology, January 1998, p. 90-93, Vol. 36, No. 1
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
van Hal, S. J., Gilgado, F., Doyle, T., Barratt, J., Stark, D., Meyer, W., Harkness, J.
(2009). Clinical Significance and Phylogenetic Relationship of Novel Australian Pneumocystis jirovecii Genotypes. J. Clin. Microbiol.
47: 1818-1823
[Abstract]
[Full Text]
-
Miller, R F, Lindley, A R, Copas, A, Ambrose, H E, Davies, R J O, Wakefield, A E
(2005). Genotypic variation in Pneumocystis jirovecii isolates in Britain. Thorax
60: 679-682
[Abstract]
[Full Text]
-
Miller, R, Huang, L
(2004). Pneumocystis jirovecii infection. Thorax
59: 731-733
[Full Text]
-
Chabe, M., Vargas, S. L., Eyzaguirre, I., Aliouat, E. M., Follet-Dumoulin, A., Creusy, C., Fleurisse, L., Recourt, C., Camus, D., Dei-Cas, E., Durand-Joly, I.
(2004). Molecular typing of Pneumocystis jirovecii found in formalin-fixed paraffin-embedded lung tissue sections from sudden infant death victims. Microbiology
150: 1167-1172
[Abstract]
[Full Text]
-
Totet, A., Duwat, H., Magois, E., Jounieaux, V., Roux, P., Raccurt, C., Nevez, G.
(2004). Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection. Microbiology
150: 1173-1178
[Abstract]
[Full Text]
-
Robberts, F. J. L., Liebowitz, L. D., Chalkley, L. J.
(2004). Genotyping and Coalescent Phylogenetic Analysis of Pneumocystis jiroveci from South Africa. J. Clin. Microbiol.
42: 1505-1510
[Abstract]
[Full Text]
-
Miller, R. F., Lindley, A. R., Ambrose, H. E., Malin, A. S., Wakefield, A. E.
(2003). Genotypes of Pneumocystis jiroveci Isolates Obtained in Harare, Zimbabwe, and London, United Kingdom. Antimicrob. Agents Chemother.
47: 3979-3981
[Abstract]
[Full Text]
-
Maskell, N A, Waine, D J, Lindley, A, Pepperell, J C T, Wakefield, A E, Miller, R F, Davies, R J O
(2003). Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax
58: 594-597
[Abstract]
[Full Text]
-
Totet, A., Pautard, J.-C., Raccurt, C., Roux, P., Nevez, G.
(2003). Genotypes at the Internal Transcribed Spacers of the Nuclear rRNA Operon of Pneumocystis jiroveci in Nonimmunosuppressed Infants without Severe Pneumonia. J. Clin. Microbiol.
41: 1173-1180
[Abstract]
[Full Text]
-
Nevez, G., Totet, A., Jounieaux, V., Schmit, J.-L., Dei-Cas, E., Raccurt, C.
(2003). Pneumocystis jiroveci Internal Transcribed Spacer Types in Patients Colonized by the Fungus and in Patients with Pneumocystosis from the Same French Geographic Region. J. Clin. Microbiol.
41: 181-186
[Abstract]
[Full Text]
-
Nimri, L. F., Moura, I. N. S., Huang, L., del Rio, C., Rimland, D., Duchin, J. S., Dotson, E. M., Beard, C. B.
(2002). Genetic Diversity of Pneumocystis carinii f. sp. hominis Based on Variations in Nucleotide Sequences of Internal Transcribed Spacers of rRNA Genes. J. Clin. Microbiol.
40: 1146-1151
[Abstract]
[Full Text]
-
Miller, R. F., Ambrose, H. E., Novelli, V., Wakefield, A. E.
(2002). Probable Mother-to-Infant Transmission of Pneumocystis carinii f. sp. hominis Infection. J. Clin. Microbiol.
40: 1555-1557
[Abstract]
[Full Text]
-
Miller, R. F., Ambrose, H. E., Wakefield, A. E.
(2001). Pneumocystis carinii f. sp. hominis DNA in Immunocompetent Health Care Workers in Contact with Patients with P. carinii Pneumonia. J. Clin. Microbiol.
39: 3877-3882
[Abstract]
[Full Text]
-
Helweg-Larsen, J., Lundgren, B., Lundgren, J. D.
(2001). Heterogeneity and Compartmentalization of Pneumocystis carinii f. sp. hominis Genotypes in Autopsy Lungs. J. Clin. Microbiol.
39: 3789-3792
[Abstract]
[Full Text]
-
NEVEZ, G., GUYOT, K., TOTET, A., RACCURT, C., DEI-CAS, E.
(2001). Pulmonary colonisation with Pneumocystis carinii in an immunosuppressed HIV-negative patient: detection and typing of the fungus by PCR. J Med Microbiol
50: 198-200
[Abstract]
[Full Text]
-
Palmer, R. J., Settnes, O. P., Lodal, J., Wakefield, A. E.
(2000). Population Structure of Rat-Derived Pneumocystis carinii in Danish Wild Rats. Appl. Environ. Microbiol.
66: 4954-4961
[Abstract]
[Full Text]
-
Vargas, S. L., A. Ponce, C., Gigliotti, F., Ulloa, A. V., Prieto, S., Muñoz, M. P., Hughes, W. T.
(2000). Transmission of Pneumocystis carinii DNA from a Patient with P. carinii Pneumonia to Immunocompetent Contact Health Care Workers. J. Clin. Microbiol.
38: 1536-1538
[Abstract]
[Full Text]